CureVac AG is a biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on innovative cancer immunotherapies, prophylactic vaccines and molecular therapies. Currently, about 470 RNA people are striving to achieve our main goal: To bring the first mRNA-based drug worldwide to the market.
To strengthen our team in Tübingen near Stuttgart, we are currently looking to recruit a
Scientist (f/m/d) Potency Analytics – Early Process Development
Job-ID: 3601 -2005
With much passion and sense of responsibility, we work together on the medical revolution. We pride ourselves on maintaining an honest and trusting relationship with each other which is characterized by openness to new ideas and continuous progress. Mutual respect, reliability and personal initiative are self-evident for us.
Design your future with us – become part of the RNA people!